View Press Releases
Proinnovera announces major change to the global clinical Dermatology landscape
MUENSTER, GERMANY - Jul 2, 2018 - proinnovera GmbH, a full-service Contract Research Organization (CRO) specialized in the conduct of clinical trials services for dermatology, today announced the establishment of the Companys wholly owned subsidiary, proinnovera Inc. in North Carolina. The Subsidiary, which opened its doors on June 1st, offers full-service clinical trial solutions for studies with dermatology, immunology, inflammatory skin diseases, skin cancer and pre-cancerous indications, burns, wounds, and aesthetics.
Proinnovera has established the US operations in response to feedback from the Companys clients, many of whom desire a reliable, specialized global dermatology CROs with a US footprint. The Company looks forward to expanding proinnoveras high-quality services, and providing the pharmaceutical industry with exceptional performance and consistency in international clinical trials services.
Were seeing the need for global reach of Dermatology studies ever increasing. We want to meet this need by offering our clients a global presence with deep and responsive local expertise, said Dr. Marion Breuer, Ph.D., who together with owner Dr. Burkhard Breuer, Ph.D., shares the role of CEO.
The Company has its sights set to become a key player in the international dermatology clinical trials market through the opening of the US operations. Proinnovera is proud to announce and welcome Sonja VanWye as the Vice President Clinical Operations for the US. Ms. VanWye will be responsible for team development, expanding the US footprint, contribute in site and vendor selection, as well as general management responsibilities.
Ms. VanWye comes to Proinnovera with 23+ years of management and quality assurance experience in clinical trials. She joins the Proinnovera team after a successful tenure as Senior Director Clinical Operations at a Dermatology specialty CRO. She has held various management positions in both the Sponsor and CRO sector. I am honored to be guiding our efforts in the expansion of the US footprint for Proinnovera. Adding professionals in the US with deep industry and therapeutic experience along with strong credentials will complement the quality of our current teams and enhance our ability to meet all the needs of our clients.
For information on clinical trials services offered by proinnovera please contact info@proinnovera.com
Proinnovera GmbH
Wienburgstraße 207
48159 Münster
Germany
Web: www.proinnovera.com
PR contact
co-operate Wegener & Rieke GmbH
Zumsandestr. 32
48145 Münster
Germany
Web: www.co-operate.net